International Cannabis Weekly: 126

• Prohibition Partners releases The UK Cannabis Report.
• Canadians spent CA$908 million on adult-use cannabis in year after legalisation.
• Uruguay’s Senate approves new bill to regulate medical cannabis.

• Denmark considers extending medical cannabis trial.
• Malta’s justice minister presents amendments to cannabis sentencing laws.
• Aurora Cannabis clarifies why operations in Germany are temporarily halted.
• British pharmacists call for clarity on CBD products.
• Tilray’s EU campus in Portugal receives additional GMP certification.
• Plena Global completes commercial CBD shipments from Colombia to Europe

• Illinois starts accepting applications for its next round of dispensary licences.
  
• Canopy Growth names Constellation Brands’ CFO as its new CEO.
• Virginia’s Attorney General leads cannabis decriminalisation summit.
  
• Texas hemp programme pends USDA approval.
• New York governor signs legislation to establish the production and sale of hemp.

• Thai Public Health Ministry launches new educational website on medical cannabis.
• iX Biopharma granted Australian cannabis manufacturing licence.
• University of Sydney awards Honorary Fellowships to two cannabis research pioneers.
• New specialist cannabis extraction facility opened in Australian state of Victoria.

• Opposition urges Trinidad and Tobago government to rework proposed cannabis bills.
• Brazil’s evangelical bench may stop re-examination of cannabis cultivation proposal.
• Peru publishes key cannabis regulations.

• Israel’s High Court orders a temporary freeze on medical cannabis reforms.
• Creso Pharma announces expansion in Africa, but shares fall regardless.
• Ugandan cabinet conducting study on legalising commercial cannabis cultivation.

• Cannabis might be disrupting the sleeping aid market, suggests new evidence.
• New study analyses motivations of chronic illness patients who seek out illicit cannabis.
• SpaceX plans to launch hemp and coffee plant cultures into space for new study.
• Scottish researchers identify genetic region that could predict reactions to cannabis.

Prohibition Partners is delighted to present The UK Cannabis Report, providing a complete and comprehensive review of cannabis regulations in the UK as well as the latest trends, insights and opportunities across the industry.

Download now

CANNABIS EUROPA MADRID: SPEAKERS ANNOUNCED

Cannabis Europa Madrid will bring together 250+ senior decision-makers to address the issues of regulating cannabis in Spain and around Europe.

Join political, scientific and business discussions led by esteemed moderators and carefully curated panels.

Buy tickets

IMN and Prohibition Partners are excited to announce the next event in our series of European cannabis investment conferences, IC3 Frankfurt, bringing investment and finance leaders to Europe’s largest cannabis market.

The IC3 conferences provide a meeting place for investors who wish to deploy capital or learn more about this exciting and high-growth new asset class, showcasing the cannabis companies and investment funds who are looking to raise money, and professional service providers who facilitate business across the industry.

Buy tickets